Information Provided By:
Fly News Breaks for June 23, 2015
VICL
Jun 23, 2015 | 11:00 EDT
Roth Capital downgraded Vical to Neutral and lowered its price target to $1.65 due to disappointing Phase I/II HSV-2 study results.
News For VICL From the Last 2 Days
There are no results for your query VICL